Cytosorbents Corporation (CTSO)
NASDAQ: CTSO · Real-Time Price · USD
1.080
0.00 (0.00%)
Aug 14, 2025, 1:50 PM - Market open
Cytosorbents Market Cap
Cytosorbents has a market cap or net worth of $67.78 million as of August 14, 2025. Its market cap has increased by 3.17% in one year.
Market Cap
67.78M
Enterprise Value
84.64M
1-Year Change
3.17%
Ranking
Category
Stock Price
$1.08
Market Cap Chart
Since December 31, 2007, Cytosorbents's market cap has increased from $5.50M to $67.78M, an increase of 1,132.41%. That is a compound annual growth rate of 15.31%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 13, 2025 | 67.80M | 36.14% |
| Dec 31, 2024 | 49.80M | 1.01% |
| Dec 29, 2023 | 49.30M | -27.07% |
| Dec 30, 2022 | 67.60M | -62.90% |
| Dec 31, 2021 | 182.20M | -47.05% |
| Dec 31, 2020 | 344.10M | 175.72% |
| Dec 31, 2019 | 124.80M | -51.19% |
| Dec 31, 2018 | 255.70M | 37.10% |
| Dec 29, 2017 | 186.50M | 34.37% |
| Dec 30, 2016 | 138.80M | -1.77% |
| Dec 31, 2015 | 141.30M | -38.99% |
| Dec 31, 2014 | 231.60M | 656.86% |
| Dec 31, 2013 | 30.60M | 11.27% |
| Dec 31, 2012 | 27.50M | -3.17% |
| Dec 30, 2011 | 28.40M | 72.12% |
| Dec 31, 2010 | 16.50M | 43.48% |
| Dec 31, 2009 | 11.50M | 475.00% |
| Dec 31, 2008 | 2.00M | -63.64% |
| Dec 31, 2007 | 5.50M | - |
| Dec 31, 2007 | 5.50M | - |
View and export this data all the way back to 2007. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 592.95B |
| Johnson & Johnson | 420.06B |
| AbbVie | 355.91B |
| UnitedHealth Group | 246.17B |
| AstraZeneca | 240.81B |
| Novartis AG | 234.72B |
| Novo Nordisk | 227.37B |
| Abbott Laboratories | 225.22B |